Get the Stockscreener App
1.66
0.00%
0.00
Nephros Inc stock is traded at $1.66, with a volume of 312.
It is up +0.00% in the last 24 hours and up +6.41% over the past month.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.
See More
Previous Close:
$1.66
Open:
$1.5845
24h Volume:
312
Relative Volume:
0.02
Market Cap:
$16.71M
Revenue:
$13.55M
Net Income/Loss:
$-929.00K
P/E Ratio:
-18.44
EPS:
-0.09
Net Cash Flow:
$-2.09M
1W Performance:
+16.14%
1M Performance:
+6.41%
6M Performance:
-10.86%
1Y Performance:
-26.55%
1-Day Range:
$1.5845
$1.5845
1-Week Range:
$1.51
$1.84
52-Week Range:
$1.3643
$2.55
Nephros Inc Stock (NEPH) Company Profile
Name
Nephros Inc
Sector
Industry
Phone
201.343.5202
Address
380 LACKAWANNA PLACE, SOUTH ORANGE, NJ
Compare NEPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 1.84 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
0.1899 | 398.43M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.79 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.58 | 113.68M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
5.13 | 65.17M | 0 | 0 | 0 | 0.00 |
|
QQQE
Direxion NASDAQ-100 Equal Weigh
|
86.44 | 0 | 0 | 0 | 0 | 0.00 |
Nephros Inc Stock (NEPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-21 | Initiated | B. Riley Securities | Buy |
Nephros Inc Stock (NEPH) Latest News
Nephros, Inc. Reports First Profitable Year - TipRanks
Earnings call transcript: Nephros Q4 2024 beats EPS forecast, stock surges - Investing.com Australia
Earnings call transcript: Nephros Q4 2024 beats EPS forecast, stock surges By Investing.com - Investing.com South Africa
Nephros Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Nephros earnings beat by $0.05, revenue topped estimates - Investing.com Canada
Nephros Inc (NEPH) Q4 Earnings: EPS of $0.02 Beats Estimate, Rev - GuruFocus.com
Nephros, Inc. Reports Fourth Quarter and Fiscal Year 2024 Financial Results - TradingView
Nephros Announces Fourth Quarter and Fiscal Year 2024 Financial Results -March 06, 2025 at 04:11 pm EST - Marketscreener.com
Earnings To Watch: Nephros Inc (NEPH) Reports Q4 2024 Result - GuruFocus.com
Nephros Amends CFO Employment Terms for Strategic Growth - TipRanks
Nephros Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
Nephros, Inc. to Host Earnings Call - ACCESS Newswire
Nephros (NEPH) Projected to Post Earnings on Thursday - Defense World
Nephros Sets Date for Q4 and Fiscal Year 2024 Financial Results Presentation - citybuzz -
Nephros Announces Submission of Special 510(k) Application to the FDA for the EndoPur(TM) Ultrafilter - ACCESS Newswire
Nephros (NASDAQ:NEPH) and Sintx Technologies (NASDAQ:SINT) Head to Head Analysis - Defense World
Nephros (NASDAQ:NEPH) Trading 1.3% Higher – Should You Buy? - Defense World
Insider Buyers Lose US$47k As Nephros Sheds US$2.0m - Simply Wall St
Nephros (FRA:NPJP) Forward Dividend Yield % : 0.00% (As of Jan. 16, 2025) - GuruFocus.com
Analysts Expect Nephros, Inc. (NASDAQ:NEPH) To Breakeven Soon - Yahoo Finance
Nephros, Inc. (NASDAQ:NEPH) Q3 2024 Earnings Call Transcript - MSN
Critical Analysis: Todos Medical (OTCMKTS:TOMDF) and Nephros (NASDAQ:NEPH) - Defense World
BioNexus Gene Lab Leads Our Top 3 US Penny Stocks - Simply Wall St
The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference - The Manila Times
Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC - The Manila Times
Nephros to Present at Benchmark's Discovery Investor Conference, CEO and CFO to Meet Key Investors - StockTitan
Nephros Inc (NEPH) Quarterly 10-Q Report - Quartzy
Results: Nephros, Inc. Confounded Analyst Expectations With A Surprise Profit - Yahoo Finance
Nephros Inc (NEPH) Q3 2024 Earnings Call Highlights: First Profi - GuruFocus.com
Nephros Inc (NEPH) Q3 2024 Earnings Call Highlights: First Profitable Quarter and Strategic ... - Yahoo Finance
Nephros, Inc. Reports First Profitable Quarter in 2024 - TipRanks
Nephros earnings beat by $0.04, revenue topped estimates - Investing.com UK
Nephros Achieves First Profitable Quarter Amid Operational Improvements - Citybuzz
Nephros Announces Financial Results for Quarter Ended September 30, 2024 - StockTitan
Nephros, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
What To Expect From Nephros Inc (NEPH) Q3 2024 Earnings - GuruFocus.com
Nephros Schedules Third Quarter 2024 Financial Results Conference Call - The Manila Times
Nephros launches HydraGuard 20″ UltraFilter - Yahoo Finance
Nephros Expands Market Reach with New HydraGuard 20″ UltraFilter - Vancity Buzz
Nephros Launches New HydraGuard 20” UltraFilter - The Manila Times
Nephros stock plunges to 52-week low of $1.43 amid market challenges - Investing.com Australia
Nephros stock plunges to 52-week low of $1.43 amid market challenges By Investing.com - Investing.com South Africa
Nephros helps hospitals and care facilities affected by Hurricanes Helene and Milton - Filtration + Separation
Nephros Provides Critical Water Filtration Solutions in Wake of Hurricanes Helene and Milton - Vancity Buzz
Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton - The Manila Times
Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes - EIN News
Nephros stock plunges to 52-week low of $1.45 amid market challenges By Investing.com - Investing.com South Africa
Nephros Inc Stock (NEPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Nephros Inc Stock (NEPH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Amron Arthur H | Director |
May 28 '24 |
Buy |
2.22 |
2,000 |
4,441 |
100,463 |
| Banks Robert R. Jr. | President and CEO |
May 16 '24 |
Buy |
2.24 |
50,000 |
112,050 |
70,000 |
0.95%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):